Sherpa Healthcare Partners Reaches Final Close for Debut US-Denominated China Fund

Source(s): DealStreetAsia

China-based Sherpa Healthcare Partners has reached a final close for US-denominated Sherpa Healthcare Fund I. The vehicle, which targeted USD200m, was oversubscribed and will invest in biopharma, gene technology, medtech, and medical services in China. The Oregon Public Employees Retirement System (PERS) recently committed USD100m to the fund. Read more